Literature DB >> 30793665

Preferences Regarding and Communication About End-of-Life Care Among Older Iranian-American Adults.

Zahra Rahemi1, Lynn M Dunphy2, David Newman2.   

Abstract

Using a cross-sectional study, this article addresses end-of-life (EOL) care for older Iranian-American adults. The purposes are twofold: (a) to explore participants' preferences for home or hospital care in the event they face EOL conditions and (b) to learn how participants prefer to communicate these preferences. Results showed that about half of the 130 participants had communicated their EOL care preferences through written documents and/or verbal discussions. A set of factors predicted the preferences (χ2(9) = 17.42, p < .042) and communications (χ2(9) = 19.54, p = .021). Regression models indicated that higher scores of social support (p = .013) and greater numbers of cohabitants (p = .021) were associated with a preference for home care, and experience of a loved one's death was associated with participants being willing to communicate their preferences for type of care (p = .015). This study can bridge the gap between culturally diverse older adults' preferences and types of EOL care they ultimately receive.

Entities:  

Keywords:  Iranian Americans; care preference; communication; end of life; end-of-life care; older adults; place of care

Year:  2019        PMID: 30793665     DOI: 10.1177/0193945919832304

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.967


  2 in total

1.  Planning Ahead for End-of-Life Healthcare among Iranian-American Older Adults: Attitudes and Communication of Healthcare Wishes.

Authors:  Zahra Rahemi
Journal:  J Cross Cult Gerontol       Date:  2019-06

2.  Design, implementation and evaluation of informal home care support intervention program for lonely older adults in the community: Protocol for a feasibility study.

Authors:  Elham Lotfalinezhad; Haidar Nadrian; Ahmad Kousha; Karen Andersen-Ranberg; Mohamed Asghari Jafarabadi; Ahmad Sohrabi; Mina Hashemiparast; Mohammad Reza Honarvar; Shannon Freeman
Journal:  PLoS One       Date:  2022-08-31       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.